AstraZeneca PLC (NASDAQ:AZN)

52.00
Delayed Data
As of Oct 23
 +0.04 / +0.08%
Today’s Change
36.15
Today|||52-Week Range
64.94
+4.29%
Year-to-Date
2 Surefire Coronavirus Stocks to Buy Right Now
Oct 24 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics
Oct 17 / MotleyFool.com - Paid Partner Content
Are Consumers and Investors Protected Against COVID-19 Vaccine Risks?
Oct 24 / MotleyFool.com - Paid Partner Content
Pfizer may file for early Covid-19 vaccine use -- but not until after the election
Oct 16 / CNN.com - Paid Partner Content
Can a Coronavirus Antibody Treatment Knock Out Moderna?
Oct 23 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: J&J's Q3 Earnings, Pause on Coronavirus Studies & Other Updates
Oct 16 / Zacks.com - Paid Partner Content
Have $1,000? 2 Fantastic Coronavirus Stocks to Buy and Hold for the Next Decade
Oct 23 / MotleyFool.com - Paid Partner Content
Forget Snowflake! 2 Hyper-Growth Stocks I'd Rather Buy
Oct 16 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN), J&J (JNJ) Coronavirus Trials May Resume Soon
Oct 22 / Zacks.com - Paid Partner Content
Moderna Gets Consent to File MAA for Coronavirus Vaccine in EU
Oct 15 / Zacks.com - Paid Partner Content
Brazil Healthcare Regulator Says Patient in AstraZeneca Coronavirus Vaccine Trial Dies
Oct 21 / MotleyFool.com - Paid Partner Content
If You Invested $1,000 in Johnson & Johnson in January, This Is How Much You Would Have Today
Oct 15 / MotleyFool.com - Paid Partner Content
2 Late-Stage Coronavirus Vaccine Candidates in Limbo
Oct 21 / MotleyFool.com - Paid Partner Content
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Oct 15 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso sNDA Receives Priority Review
Oct 21 / Zacks.com - Paid Partner Content
Eli Lilly Coronavirus Antibody Drug Trial Paused
Oct 14 / MotleyFool.com - Paid Partner Content
Merck (MRK) to Report Q3 Earnings: Is a Beat in the Cards?
Oct 21 / Zacks.com - Paid Partner Content
Stock Market News for Oct 14, 2020
Oct 14 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: NVIDIA, Salesforce, AstraZeneca, JPMorgan and Chevron
Oct 21 / Zacks.com - Paid Partner Content
Don't buy the stock market hype around coronavirus vaccine and treatment companies
Oct 14 / CNN.com - Paid Partner Content
How Profitable Is Coronavirus Vaccine Development?
Oct 21 / MotleyFool.com - Paid Partner Content
Lilly's Coronavirus Antibody Study Paused on Safety Concerns
Oct 14 / Zacks.com - Paid Partner Content
U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon
Oct 20 / MotleyFool.com - Paid Partner Content
5 Must-Buy Blue Chip Stocks to Remain Safe in October
Oct 14 / Zacks.com - Paid Partner Content
Top Analyst Reports for NVIDIA, salesforce & AstraZeneca
Oct 20 / Zacks.com - Paid Partner Content
Here Are the Only 2 Coronavirus Vaccines That Could Meet the FDA's Authorization Guidelines by Year-End
Oct 14 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Gets CHMP Nod for Forxiga in Heart Failure
Oct 20 / Zacks.com - Paid Partner Content
Sanofi's Dupixent Meets All Goals in Asthma Study for Children
Oct 13 / Zacks.com - Paid Partner Content
What's the Outlook for AstraZeneca Stock?
Oct 20 / MotleyFool.com - Paid Partner Content
2 Great Stocks to Buy With Just $100
Oct 13 / MotleyFool.com - Paid Partner Content
Astrazeneca (AZN) Stock Moves -1.11%: What You Should Know
Oct 19 / Zacks.com - Paid Partner Content
Is the Coronavirus Vaccine Market Oversaturated?
Oct 13 / MotleyFool.com - Paid Partner Content
Bristol-Myers' (BMY) Opdivo Gets Positive CHMP View for ESCC
Oct 19 / Zacks.com - Paid Partner Content
J&J's Coronavirus Vaccine Studies Paused Post Adverse Event
Oct 13 / Zacks.com - Paid Partner Content
CVS is filling thousands of pharmacy jobs to battle coronavirus
Oct 19 / CNN.com - Paid Partner Content
Coronavirus Vaccine Side Effects: 3 Key Things You Need to Know
Oct 13 / MotleyFool.com - Paid Partner Content
Better Buy: Amgen vs. Bristol Myers Squibb
Oct 18 / MotleyFool.com - Paid Partner Content
Report: Johnson & Johnson Coronavirus Vaccine Study Paused Due To Participant's Unexplained Illness
Oct 12 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?
Oct 18 / MotleyFool.com - Paid Partner Content
Astrazeneca (AZN) Gains But Lags Market: What You Should Know
Oct 12 / Zacks.com - Paid Partner Content
Better Coronavirus Stock: AstraZeneca or Johnson & Johnson
Oct 17 / MotleyFool.com - Paid Partner Content
AstraZeneca's Coronavirus Antibody Therapy to Enter Late Stage
Oct 12 / Zacks.com - Paid Partner Content
What You Need to Know at This Stage of the Coronavirus Vaccine Race
Oct 17 / MotleyFool.com - Paid Partner Content
Alkermes' Schizophrenia Drug Gets Favorable FDA Panel Vote
Oct 12 / Zacks.com - Paid Partner Content
Is Guardant Health Stock a Buy?
Oct 17 / MotleyFool.com - Paid Partner Content
Pfizer's (PFE) Ibrance Fails in Early Breast Cancer Study
Oct 12 / Zacks.com - Paid Partner Content
Why I Think Bristol Myers Squibb Is Too Cheap to Miss
Oct 17 / MotleyFool.com - Paid Partner Content
Is Novavax Stock Too Risky to Buy Today?
Oct 12 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: AstraZeneca or Moderna?
Oct 17 / MotleyFool.com - Paid Partner Content
Why Is Everyone Talking About Inovio Stock?
Oct 12 / MotleyFool.com - Paid Partner Content